Petition urges GSK and Pfizer to lower price of pneumonia vaccineBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2455 (Published 29 April 2016) Cite this as: BMJ 2016;353:i2455
- Zosia Kmietowicz
- The BMJ
The humanitarian charity Médecins Sans Frontières/Doctors Without Borders has delivered a petition of almost 400 000 signatures to the headquarters of GlaxoSmithKline (GSK) in London and Pfizer in New York, demanding that the companies reduce the price of their pneumonia vaccine in developing countries to $5 (£3.45; €4.40) per child.
The petition was delivered to GSK by an …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial